Earnings turnaround and raised outlook put Clover Health Investments in focus

Clover Health Investments (CLOV) is in focus after reporting second quarter 2026 results that shifted from a net loss to net income and after management raised full year revenue and GAAP net income guidance.

The latest earnings turnaround and raised outlook come after a steep 18.18% decline in the 30 day share price return. However, Clover Health Investments still shows a 71.78% year to date share price return and 83.19% 1 year total shareholder return, suggesting that longer term momentum has been much stronger than the recent pullback.

If this kind of volatility has your attention, it may be a good moment to see what else is moving in the sector through a healthcare focused screener such as 42 healthcare AI stocks

Clover Health Investments has just shifted into profit and lifted guidance, yet the stock recently pulled back after a strong run. Is this now a solid Medicare business at a stretched price, or still reasonable value?

Most Popular Narrative: 20% Undervalued

The most followed narrative sets a fair value for Clover Health Investments at $4.15, slightly above the last close of $4.14, and ties that gap to ambitious long term earnings and revenue assumptions.

The company's differentiated technology-driven care model, particularly the Clover Assistant platform, positions it to benefit from the healthcare industry's accelerated shift toward technology adoption and data-driven, value-based care, supporting lower medical costs and higher medical margins, with positive implications for both revenue growth and net margins.

Want to see what earnings trajectory and margin path need to line up for that fair value. The narrative leans on faster revenue growth and a richer future profit multiple that is well above the broader healthcare sector. Curious which specific long term assumptions need to land for that to hold.

Result: Fair Value of $4.15 (UNDERVALUED)

However, Clover Health Investments still faces clear pressure points, including higher medical and pharmacy utilization, as well as potential Medicare Advantage reimbursement or policy changes that could hit margins and earnings expectations.

Next Steps

With mixed sentiment around Clover Health Investments, this is a good time to move quickly, look through the numbers yourself, and decide where you stand. To balance the concerns against the potential upside, review the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Clover Health Investments?

If you are weighing your next move after reading about Clover Health Investments, do not stop here. Fresh ideas can help keep your portfolio flexible, resilient, and ready for the next opportunity.

• Zero in on companies that combine quality with potential value by checking stocks in the 51 high quality undervalued stocks.
• Strengthen the foundation of your portfolio by reviewing companies in the solid balance sheet and fundamentals stocks screener (50 results).
• Stay ahead of the crowd by scanning opportunities in the screener containing 17 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.